[Expression and Regulatory Effect of miR-30b on Dynamin in Cochlear Hair Cells].

Sichuan Da Xue Xue Bao Yi Xue Ban

Department of Otolaryngology Head and Neck Surgery,Southwest Hospital, Third Military Medical University,Chongqing 400038,China.

Published: May 2018


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To determine the expression of miR-30b in hair cells of mice,and its regulatory effect on the target gene 1 and expression of Dynamin,the key protein of synaptic endocytosis in inner hair cells.

Methods: The basilar membrane of cochlear in adult C57 mice was obtained. The expression of miR-30b in the hair cells was detected by in situ hybridization. Luciferase vector was constructed and transfected into 293T cells with miR-30b. Changes in luciferase activity were measured to verify whether 1 was the target gene of miR-30b. Adeno-associated virus carrying miR-30b were micro-injected into cochlear via the round window membrane. mRNA expressions of 1 and miR-30b were detected by RT-PCR 14 days later. The expression of Dynamin was detected by Western blot.

Results: miR-30b expressed in the inner and outer hair cells scattered in the region of the nucleus and cytoplasm. miR-30b reduced luciferase activity from the reporter vector containing 11 (<0.05),but not in its mutants. Increased expressions of miR-30b and decreased mRNA expressions of 1 and Dynamin were observed following transfection of AAV-miR-30b.

Conclusion: miR-30b expresses in inner and outer hair cells,which is consistent with the morphological orientation of dynamin. miR-30b inhibits the expression of Dynamin by targeting 11 gene.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hair cells
12
mir-30b
9
expression mir-30b
8
mir-30b hair
8
target gene
8
luciferase activity
8
hair
5
[expression regulatory
4
regulatory mir-30b
4
mir-30b dynamin
4

Similar Publications

modulates presynaptic Ca1.3 Ca channel function in inner hair cells (IHCs) and is required for indefatigable synaptic sound encoding. Biallelic variants in are associated with non-syndromic hearing loss (DFNB93).

View Article and Find Full Text PDF

Clinical Doses of Gadodiamide Have No Damaging Effects on Cochlear Tissue In Vitro and In Vivo.

Neurotoxicology

September 2025

Department of Otolaryngology Head and Neck Surgery, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China. Electronic address:

Gadolinium-based contrast agents (GBCAs) are widely used in systemic magnetic resonance imaging (MRI) and can be employed in otology to evaluate endolymphatic hydrops in patients with Ménière's disease. Given the heavy metal properties of gadolinium and its tendency to deposit in tissues, it is essential to assess its ototoxic risk. We evaluated the ototoxicity of gadodiamide using in vitro and in vivo models.

View Article and Find Full Text PDF

Morphogenetic information arises from a combination of genetically encoded cellular properties and emergent cellular behaviors. The spatio-temporal implementation of this information is critical to ensure robust, reproducible tissue shapes, yet the principles underlying its organization remain unknown. We investigated this principle using the mouse auditory epithelium, the organ of Corti (OC).

View Article and Find Full Text PDF

Background: Persistent chemotherapy-induced alopecia (pCIA) is a distressing side effect of antineoplastic agents, imposing significant psychological burdens on cancer survivors. Despite its impact, there are no standardized guidelines for diagnosis, prevention or management.

Objective: To establish consensus-based definitions, diagnostic criteria, grading systems and management recommendations for pCIA.

View Article and Find Full Text PDF

Magnetic Targeting of AAV Gene Therapy for Inner Ear Following Systemic Delivery: Preliminary Findings and Transduction Pattern in Rat Cochlea.

J Assoc Res Otolaryngol

September 2025

Biological Sciences Platform, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room M1 102, Toronto, ON, M4N 3M5, Canada.

Purpose: Delivery of therapeutics to the inner ear is complicated by their inaccessible location and the presence of the blood-labyrinth barrier that restricts most blood-borne compounds from entering the inner ear. This study addresses the challenge of optimal delivery in treating inner ear disease, focusing on magnetic targeting gene therapy using adeno-associated virus (AAV).

Methods: The investigation explores three AAV serotypes (AAV2 Quad Mut, AAV2 pANC80L65, and AAV9 PHP.

View Article and Find Full Text PDF